We are live on ! Find out more
AC

Amia Capital Portfolio holdings

AUM $32.1M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+33.38%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.2M
AUM Growth
-$11.9M
Cap. Flow
-$30.5M
Cap. Flow %
-41.17%
Top 10 Hldgs %
100%
Holding
36
New
1
Increased
1
Reduced
2
Closed
30

Top Buys

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$3.56M
2
INTC icon
Intel
INTC
+$488K

Top Sells

Rank Stock Value
1
VALE icon
Vale
VALE
+$8M
2
GRFS
Grifois
GRFS
+$5.68M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$2.02M
4
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
+$1.7M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$1.53M

Sector Composition

Rank Sector Weight
1 Energy 25.76%
2 Healthcare 24.6%
3 Materials 6.78%
4 Technology 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBR icon
1
Petrobras
PBR
$122B
$19.1M 25.76%
1,700,900
+400,900
+31% +$3.56M
GRFS
2
Grifois
GRFS
$5.39B
$18.2M 24.6%
989,087
-306,391
-24% -$5.68M
LSXMK
3
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$16M 21.58%
474,803
– –
LSXMA
4
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$15.3M 20.61%
481,627
– –
VALE icon
5
Vale
VALE
$62.3B
$5.03M 6.78%
300,000
-600,000
-67% -$8M
INTC icon
6
Intel
INTC
$531B
$498K 0.67%
+10,000
New +$488K
AGIO icon
7
Agios Pharmaceuticals
AGIO
$2.17B
– –
-21,740
Closed -$761K
ALNY icon
8
Alnylam Pharmaceuticals
ALNY
$35.8B
– –
-6,937
Closed -$1.01M
ARGX icon
9
argenx
ARGX
$54.2B
– –
-5,077
Closed -$1.33M
BDTX icon
10
Black Diamond Therapeutics
BDTX
$105M
– –
-7,589
Closed -$229K
CDTX
11
DELISTED
Cidara Therapeutics
CDTX
– –
-770
Closed -$44K
CRSP icon
12
CRISPR Therapeutics
CRSP
$4.67B
– –
-4,374
Closed -$366K
ESPR
13
DELISTED
Esperion Therapeutics
ESPR
– –
-20,464
Closed -$761K
EXEL icon
14
Exelixis
EXEL
$14B
– –
-15,479
Closed -$378K
FATE icon
15
Fate Therapeutics
FATE
$311M
– –
-10,209
Closed -$408K
HALO icon
16
Halozyme
HALO
$9.33B
– –
-36,279
Closed -$953K
INCY icon
17
Incyte
INCY
$23.5B
– –
-15,939
Closed -$1.43M
IONS icon
18
Ionis Pharmaceuticals
IONS
$8.58B
– –
-42,552
Closed -$2.02M
KZR
19
DELISTED
Kezar Life Sciences
KZR
– –
-2,315
Closed -$112K
MGNX icon
20
MacroGenics
MGNX
$275M
– –
-24,131
Closed -$608K
MRNA icon
21
Moderna
MRNA
$23.4B
– –
-17,607
Closed -$1.25M
NBIX icon
22
Neurocrine Biosciences
NBIX
$18B
– –
-15,939
Closed -$1.53M
NKTR icon
23
Nektar Therapeutics
NKTR
$2.33B
– –
-953
Closed -$237K
SAGE
24
DELISTED
Sage Therapeutics
SAGE
– –
-7,644
Closed -$467K
SGMO
25
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-21,018
Closed -$199K
1
2

Similar funds

QI
Qualcomm Inc San Diego, California $32.1M AUM 5.35% 1-Year Est. Return
SAM
Sandbar Asset Management London, United Kingdom $30.5M AUM 46.07% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
AG
Appleton Group Appleton, Wisconsin $28.6M AUM 32.21% 1-Year Est. Return
NLG
New Legacy Group New York $36.6M AUM 36.77% 1-Year Est. Return
BEVI
Braemar Energy Ventures III New York $37.9M AUM 66.45% 1-Year Est. Return
BGDR
BC Gestao de Recursos Sao Paulo, Brazil $38.2M AUM
TAAM
Top Ace Asset Management Hong Kong $25.3M AUM 23.27% 1-Year Est. Return

Amia Capital's Q4 2020 Portfolio in Review

As of Q4 2020, Amia Capital held 36 positions worth $74.2M, down 14% from $86.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Amia Capital withdrew a net $30.5M in Q4 2020, closing 30 positions and reducing 2 holdings. Its most notable exit was Ionis Pharmaceuticals, an estimated $2.02M position sold in full.

By sector, the portfolio is most concentrated in Energy at 26% of assets, up from 11% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Amia Capital opened a new position in Intel worth $498K.

  • Amia Capital's largest Q4 2020 buy was Intel: 10,000 shares worth $498K.
  • Amia Capital added most to Petrobras in Q4 2020, an estimated $3.56M increase.
  • Amia Capital's biggest Q4 2020 reduction was Vale, cutting an estimated $8M.
  • Amia Capital fully exited Ionis Pharmaceuticals in Q4 2020, selling an estimated $2.02M.
  • Amia Capital's ten largest holdings make up 100% of its $74.2M portfolio in Q4 2020.
  • Amia Capital opened 1 new position and closed 30 in Q4 2020.
  • Amia Capital's portfolio value fell 14% quarter-over-quarter to $74.2M.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.